hotspot -WSS

hotspot

author：focus 2025-09-30 16:29:25 - browse：64

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Dementia risk linked to living in disadvantaged areas: Study

WSS

FDA approves world's first CRISPR

After sickle

When a patient nears the end, a feared therapy can comfort

In diabetes hearing, Sanders takes on a new foe: food makers

'CMA Fest' 2023: How to watch, who is performing and more

Extensive review finds private equity owners jack up cost of care

focus

hotspot

explore

Affirmative action in medical school literally saved lives

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Telehealth startups are trying to fill the menopause care vacuum

Psychedelics group wrestles with new pharma identity

Pregnancy discrimination could be enabled by AI

BioMarin wins approval for gene therapy to treat hemophilia A

Hormonal contraceptives don’t actually treat endometriosis

Apple is now the first public company to be valued at $3 trillion

Hormonal contraceptives don’t actually treat endometriosis

leisure time

Pfizer plans to depart BIO

FDA needs staff influx to meet gene therapy needs, Marks says

When a patient nears the end, a feared therapy can comfort

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Extensive review finds private equity owners jack up cost of care

leisure time

leisure time

knowledge

focus